Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–12 of 12 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT05098210
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Bronchial Neoplasms, Carcinoma, Bronchogenic, +46 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT06265285
- Conditions
- Adenocarcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, +81 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT07627698
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +17 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
NCT07155317
- Conditions
- Advanced Acral Melanoma, Advanced Cutaneous Melanoma, Advanced Mucosal Melanoma, +19 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
NCT04511013
- Conditions
- Acral Lentiginous Melanoma, Brain Diseases, Brain Neoplasms, +22 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
- Locations
-
- EuroCityClinic LLC Saint Petersburg, Sankt-Peterburg, Russia
Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy
NCT07628894
- Conditions
- Advanced Cutaneous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, +13 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
NCT07576725
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
- Locations
-
- Uganda Cancer Institute Kampala, Uganda
Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma
NCT07183852
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +16 more
- Locations
-
Not specified
Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases
NCT05903937
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +15 more
- Locations
-
Not specified
NCT04812470
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +16 more
- Locations
-
- Department of Oncology, Sahlgrenska University Hospital Gothenburg, Sweden
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
NCT02506153
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma, +18 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Virginia G Piper Cancer Care-Del Camino Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States